Advertisement

Topics

Sandoz Receives EU Approval for Rituximab Biosimilar

14:00 EDT 20 Jun 2017 | Drug Discovery Development

Sandoz is committed to increasing patient access to high-quality, life-enhancing biosimilar medicines.
Contributed Author: 
Sandoz
Topics: 

Original Article: Sandoz Receives EU Approval for Rituximab Biosimilar

NEXT ARTICLE

More From BioPortfolio on "Sandoz Receives EU Approval for Rituximab Biosimilar"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Biosimilars
Biosimilars or Follow-on biologics are terms used to describe officially approved subsequent versions of innovator biopharmaceutical products made by a different sponsor following patent and exclusivity expiry on the innovator product. Products that ar...